Episode 24: Clinical considerations: Managing treatment switches
From Thrombosis in conversation by medthority
January 7, 2025 · 21 min · Episode 24
About this episode
Dr Arthur Allen joins Dr Barnes to discuss managing transitions between anticoagulants and the factors influencing treatment decisions.
Clinical pharmacist Dr Arthur Allen joins Dr Barnes to discuss how to navigate transitions between anticoagulants, including when and why to use bridging low-molecular-weight heparin, the patient characteristics that may influence management, and why switching guidance in the prescribing information is not practical. Also, amid local variations in care models and cultures, what is the key factor that can determine the success of physician–pharmacist collaborative care?
People in this episode
Host: Dr Barnes
Guest: Dr Arthur Allen
Topics covered
- anticoagulants
- treatment switches
- bridging low-molecular-weight heparin
- physician-pharmacist collaboration
- patient management
Keywords
- anticoagulants
- treatment switches
- bridging therapy
- low-molecular-weight heparin
- collaborative care
- patient characteristics
- prescribing information
Mentioned in this episode
Organizations: medthority
More episodes of Thrombosis in conversation
- Episode 33: The emotional toll of VTE: A patient’s perspective · December 4, 2025 · 25 min
- Episode 32: 2025 breakthroughs in VTE and AF · November 26, 2025 · 27 min
- Episode 31: Optimising treatment duration for thrombosis · October 10, 2025 · 26 min
- Episode 30: VTE and AF at ESC 2025 · September 10, 2025 · 36 min
- Episode 29: Individualised care in special populations · March 18, 2025 · 20 min
- Episode 28: Real-world evidence: Addressing gaps in VTE and AF clinical research · March 6, 2025 · 20 min
Explore listener stats, chart rankings, contacts and more on the Thrombosis in conversation podcast page.